share_log

亨迪药业(301211.SZ):2023年公司布洛芬产量4500多吨,占据全球头部市场地位

Hengdi Pharmaceutical (301211.SZ): In 2023, the company's production of ibuprofen will be over 4500 tons, occupying a leading position in the global market.

Gelonghui Finance ·  Jun 14 03:20

On June 13, 2024, Hengdi Pharmaceutical (301211.SZ) accepted inquiries from specific parties regarding the "production scale and market share of ibuprofen active pharmaceutical ingredients." The company responded that in 2023, the company produced more than 4,500 tons of ibuprofen, occupying a leading market position globally. After years of competition and elimination, the number of global suppliers is limited, and the company has established a leadership position in the industry with high barriers to entry.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment